CN105749037A - Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease and preparation method and application thereof - Google Patents
Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease and preparation method and application thereof Download PDFInfo
- Publication number
- CN105749037A CN105749037A CN201610192449.1A CN201610192449A CN105749037A CN 105749037 A CN105749037 A CN 105749037A CN 201610192449 A CN201610192449 A CN 201610192449A CN 105749037 A CN105749037 A CN 105749037A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- rhizoma
- inflammatory disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating a chronic pelvic inflammatory disease and a preparation method and application thereof.The traditional Chinese medicine composition is prepared from roots of red-rooted salvia, radix paeoniae rubra, prepared frankincense and myrrh, cortex lycii radicis, fructus forsythiae, herba patriniae, Szechwan Chinaberry fruit, rhizoma corydalis, coix seeds, common yam rhizomes, dried rehamnnia roots, root-bark of tree peony, panax notoginseng and spreading hedyotis herb, and the traditional Chinese medicine composition can also be prepared from sargentg loryvine stems, herba taraxaci, herba patriniae, roots of red-rooted salvia, radix paeoniae rubra, rhizoma corydalis, rhizoma cyperi, rhizoma sparganii and rhizoma curcumae.The first traditional Chinese medicine composition is suitable for being taken orally, and the second traditional Chinese medicine composition is suitable for clysis.The traditional Chinese medicine composition is used for treating the chronic pelvic inflammatory disease and is definite in curative effect, safe, easy to operate, low in cost, capable of achieving noninvasive treatment and suitable for application and popularization.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition treating chronic pelvic inflammatory disease and its preparation method and application.
Background technology
Chronic pelvic inflammatory disease sickness rate is high, and its disease rates in women is generally 30% 50%, and has the trend risen year by year.80% married woman betiding 20～70 years old and old people, has a strong impact on the healthy of women and quality of life.The Therapeutic Method being applied to now chronic pelvic inflammatory disease is a lot, but in the recent period and late result all undesirable.
Summary of the invention
It is an object of the invention to provide a kind of Chinese medicine composition treating chronic pelvic inflammatory disease and its preparation method and application, this Chinese medicine composition can solve and effectively treat chronic pelvic inflammatory disease, determined curative effect, and safety is high, low cost.
For solving above-mentioned technical problem, the technical solution adopted in the present invention is: a kind of Chinese medicine composition treating chronic pelvic inflammatory disease, it is characterised in that, it includes following raw material by weight: Radix Salviae Miltiorrhizae 15-30 part, Radix Paeoniae Rubra 10-15 part, and breast processed does not have 10-12 part, Cortex Lycii 8-10 part, Fructus Forsythiae 12-15 part, Herba Patriniae 15-20 part, Fructus Toosendan 9-12 part, Rhizoma Corydalis 10-15 part, Semen Coicis 20-30 part, Rhizoma Dioscoreae 12-15 part, Radix Rehmanniae 10-15 part, Cortex Moutan 9-12 part, Radix Notoginseng 9-15 part, Herba Hedyotidis Diffusae 20-30 part.
In preferred scheme, the following raw material including by weight: Radix Salviae Miltiorrhizae 30 parts, Radix Paeoniae Rubra 15 parts, breast processed does not have 12 parts, Cortex Lycii 10 parts, Fructus Forsythiae 15 parts, Herba Patriniae 20 parts, Fructus Toosendan 12 parts, Rhizoma Corydalis 10 parts, Semen Coicis 30 parts, Rhizoma Dioscoreae 15 parts, 15 parts of the Radix Rehmanniae, Cortex Moutan 10 parts, Radix Notoginseng 15 parts, Herba Hedyotidis Diffusae 30 parts.
The method preparing described Chinese medicine composition, concretely comprises the following steps: weigh all of raw medicinal material by proportioning, and then adding water decocts, and filters and obtain the Chinese medicine composition for the treatment of chronic pelvic inflammatory disease.
The invention still further relates to the application in the medicine of preparation treatment chronic pelvic inflammatory disease of the described Chinese medicine composition.
The invention still further relates to the application in the oral drugs of preparation treatment chronic pelvic inflammatory disease of the described Chinese medicine composition.
A kind of Chinese medicine composition treating chronic pelvic inflammatory disease, it includes following raw material by weight: Caulis Sargentodoxae 20-30 part, Herba Taraxaci 20-30 part, Herba Patriniae 20-30 part, Radix Salviae Miltiorrhizae 12-15 part, Radix Paeoniae Rubra 12-15 part, Rhizoma Corydalis 12-15 part, Rhizoma Cyperi 12-15 part, Rhizoma Sparganii 10-15 part, Rhizoma Curcumae 10-15 part.
In preferred scheme, the following raw material including by weight: Caulis Sargentodoxae 30 parts, Herba Taraxaci 30 parts, Herba Patriniae 30 parts, 15 parts of Radix Paeoniae Rubra of Radix Salviae Miltiorrhizae 15 parts, Rhizoma Corydalis 15 parts, Rhizoma Cyperi 15 parts, Rhizoma Sparganii 15 parts, Rhizoma Curcumae 15 parts.
The method preparing described Chinese medicine composition, concretely comprises the following steps: weigh all of raw medicinal material by proportioning, and then adding water decocts, cross leaching filtering residue and add water further decoction, filter, merge twice filtrate, dense decoct the 1/4-1/3 to filtrate volume, the Chinese medicine composition of chronic pelvic inflammatory disease must be treated.
The invention still further relates to the application in the medicine of preparation treatment chronic pelvic inflammatory disease of the described Chinese medicine composition.
The invention still further relates to the application in the enema medicament of preparation treatment chronic pelvic inflammatory disease of the described Chinese medicine composition.
This Chinese medicine composition effect that side's compatibility plays clearing away heat-damp and promoting diuresis altogether entirely, blood-activating analgetic, eliminating stagnation disappear.Additionally, owing to having abundant tremulous pulse, vein, lymphatic plexus, rich blood vessel, slow blood flow around rectum, rectal mucosa with pelvic organ is adjacent and tube wall is thin, rectal mucosa has very strong absorption function, is used as enema medicament by this Chinese medicine composition, makes effective ingredient pass through the infiltration of rectal wall, absorbs and make medicine direct invasion, infiltrate into pelvic cavity, Uterine lesion position surrounding tissue, strengthen regional blood flow, improve microcirculation, promote anti-inflammatory drug local absorption.Improving local pain and inflammatory symptom, promote the connective tissue softening of adhesion, eliminate contrafluxion edema, make to thicken, increase thick adnexa tissue adhesion and disappear, enclosed mass reduces.Reach the effect of antiinflammatory, sterilization, detumescence, removing blood stasis with potent drugs, eliminating stagnation.
Bitter cold medicine can be alleviated to spleen injury by herbal retention enema, and be directly entered pelvic cavity viscera blood circulation after drug absorption can be made, through focus, improves local drug concentration；Additionally the Traditional Chinese medicine composition liquid medicine of coloclysis controls temperature at 37～40 DEG C after having boiled, and can distend the blood vessels, improve local blood circulation and histotrophic nutrition, reduce inflammatory seep, being conducive to suppressing connective tissue proliferation, promoting that inflammation enclosed mass absorbs, thus improving the cure rate of chronic pelvic inflammatory disease.
In raw medicinal material involved in the present invention, respective control effect and mechanism is as follows.
Herba Patriniae: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, dampness removing is treating stranguria.
Fructus Forsythiae: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.
SHECAO: heat-clearing and toxic substances removing, dampness removing is treating stranguria.
Radix Paeoniae Rubra: clearing away heat and cooling blood, repercussive pain relieving.
The Radix Rehmanniae: clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting.
Cortex Moutan: clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling.
Myrrha: promoting blood circulation and stopping pain, detumescence and promoting granulation.
Olibanum: invigorate blood circulation, promoting the circulation of QI to relieve pain, detumescence and promoting granulation.
Rhizoma Corydalis: invigorate blood circulation, circulation of qi promoting, pain relieving.
Radix Salviae Miltiorrhizae: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood disappears harmony, and relieving restlessness is calmed the nerves.
Cortex Lycii: removing heat from blood is except steaming, lung heat clearing pathogenic fire reducing.Hectic fever night sweat, dysphoria with feverish sensation in the chest palms and soles, add use during soreness of the waist and knees.
Semen Coicis: promoting diuresis to eliminate damp pathogen, spleen invigorating eliminating impediment, clearing away heat and discharging pus.Profuse leukorrhea, yellow skin adds use.
Fructus Toosendan: promoting the circulation of QI to relieve pain, parasite killing.Pain in the lumbar region, leucorrhea has abnormal flavour to add use.
Rhizoma Dioscoreae: supplementing QI and nourishing YIN, tonifying the lung spleen kidney.Reinforcement and elimination in combination.
Radix Notoginseng: hemostasis, dissipating blood stasis, detumescence, analgesic therapy.Few abdomen pain adds use
Herba Taraxaci: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, dampness removing is treating stranguria.
Rhizoma Sparganii: removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving.
Rhizoma Curcumae: removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving.
Radix Salviae Miltiorrhizae: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood disappears harmony, and relieving restlessness is calmed the nerves.
Rhizoma Cyperi: dispersing the stagnated live-QI to relieve the stagnation of QI, regulate the flow of vital energy and in, drying dampness to eliminate phlegm.
Caulis Sargentodoxae: promoting the circulation of blood is enriched blood, regulating menstruation, soothing the channels and quicking the network vessels.Eliminating evil and just do not hinder.
The cause of disease of chronic pelvic inflammatory disease, epidemiology, histopathology and clinicing aspect are conducted in-depth research by Chinese scholars in recent decades, some undergoing chronic pelvic inflammation do not have the clinical evidence that antibacterial infects, and the state of an illness is still continuing to progress from, therefore reason can not be explained by alone infective inflammation.By the research to undergoing chronic pelvic inflammation peritoneal fluid composition, there is immune system dysfunction in discovery, the too much a series of inflammatory mediator of secretion of immunocyte, cytokine, somatomedin and the antibody activated, promotes that the further hypertrophy of pelvic cavity connective tissue increases the weight of the state of an illness.And by undergoing chronic pelvic inflammation microcirculation, hemorheological research, it has been found that become Hyperviscosity syndrome state more.Hemorheological property may result in blood circulation and microcirculation disturbance, causes a series of serious consequences such as tissue ischemia, anoxia, metabolism and functional disorder.Visible, the morbidity for the treatment of chronic pelvic inflammatory disease is relevant with body's immunity disorder.Adopting traditional Chinese medicine composition for treating chronic pelvic inflammatory disease provided by the invention, safety is good, effective percentage is high.
The first Chinese medicine composition provided in the present invention is adopted to be used for being administered orally, the second Chinese medicine composition is used for coloclysis, curative effect is more notable, and chronic pelvic inflammatory disease is alleviated by stomachache after extract oral, enema treatment, leucorrhea reduces, the eumenorrhea, all can participate in normal work or physical labor；It is effectively improved female life quality, improves the productivity of family and society.Above-mentioned Chinese medicine composition can make patients symptomatic eliminate gradually or alleviate, and cure rate reaches 55%, and effective percentage is high by 90%.
It also has the advantage that (1) noinvasive, recovers fast, recovers thoroughly.(2) simple to operate, it is easy to promote.(3) safety is high, patient is acceptant.(4) expense is relatively low, and most patients all can accept.There is good Social benefit and economic benefit.(5) can effective relief of symptoms, improve physiological function, it is to avoid or reduce gynaecopathia, reduce the risk of disease progression, and be conducive to the hospital stays repairing and can effectively shortening patient of impaired internal organs.
Detailed description of the invention
Below in conjunction with being embodied as and form, it is further elucidated with the present invention.These embodiments are interpreted as being merely to illustrate the present invention rather than for limiting the scope of the invention.After having read the content that the present invention records, the present invention can be made various changes or modifications by those skilled in the art, and these equivalence changes and modification fall into claims of the present invention limited range equally.
Embodiment 1: a kind of Chinese medicine composition, the following raw material including by weight: Radix Salviae Miltiorrhizae 30 parts, Radix Paeoniae Rubra 15 parts, breast processed does not have 12 parts, Cortex Lycii 10 parts, Fructus Forsythiae 15 parts, Herba Patriniae 20 parts, Fructus Toosendan 12 parts, Rhizoma Corydalis 10 parts, Semen Coicis 30 parts, Rhizoma Dioscoreae 15 parts, 15 parts of the Radix Rehmanniae, Cortex Moutan 10 parts, Radix Notoginseng 15 parts, Herba Hedyotidis Diffusae 30 parts.
Embodiment 2: a kind of Chinese medicine composition, the following raw material including by weight: Radix Salviae Miltiorrhizae 18 parts, Radix Paeoniae Rubra 12 parts, breast processed does not have 15 parts, Cortex Lycii 10 parts, Fructus Forsythiae 15 parts, Herba Patriniae 18 parts, Fructus Toosendan 12 parts, Rhizoma Corydalis 10 parts, Semen Coicis 30 parts, Rhizoma Dioscoreae 12 parts, 12 parts of the Radix Rehmanniae, Cortex Moutan 12 parts, Radix Notoginseng 12 parts, Herba Hedyotidis Diffusae 30 parts.
Embodiment 3: a kind of Chinese medicine composition, the following raw material including by weight: Radix Salviae Miltiorrhizae 20 parts, Radix Paeoniae Rubra 12 parts, breast processed does not have 12 parts, Cortex Lycii 9 parts, Fructus Forsythiae 12 parts, Herba Patriniae 20 parts, Fructus Toosendan 12 parts, Rhizoma Corydalis 15 parts, Semen Coicis 20 parts, Rhizoma Dioscoreae 12 parts, 12 parts of the Radix Rehmanniae, Cortex Moutan 10 parts, Radix Notoginseng 10 parts, Herba Hedyotidis Diffusae 30 parts.
Embodiment 4: a kind of Chinese medicine composition, the following raw material including by weight: Radix Salviae Miltiorrhizae 15 parts, Radix Paeoniae Rubra 10 parts, breast processed does not have 12 parts, Cortex Lycii 9 parts, Fructus Forsythiae 12 parts, Herba Patriniae 15 parts, Fructus Toosendan 10 parts, Rhizoma Corydalis 12 parts, Semen Coicis 20 parts, Rhizoma Dioscoreae 12 parts, 10 parts of the Radix Rehmanniae, Cortex Moutan 9 parts, Radix Notoginseng 9 parts, Herba Hedyotidis Diffusae 20 parts.
Embodiment 5: a kind of Chinese medicine composition, the following raw material including by weight: Radix Salviae Miltiorrhizae 15 parts, Radix Paeoniae Rubra 12 parts, breast processed does not have 12 parts, Cortex Lycii 10 parts, Fructus Forsythiae 12 parts, Herba Patriniae 18 parts, Fructus Toosendan 9 parts, Rhizoma Corydalis 12 parts, Semen Coicis 30 parts, Rhizoma Dioscoreae 15 parts, 15 parts of the Radix Rehmanniae, Cortex Moutan 12 parts, Radix Notoginseng 10 parts, Herba Hedyotidis Diffusae 20 parts.
Time prepared by above-mentioned Chinese medicine composition, weighing all of raw medicinal material by proportioning, then adding water decocts, and filters and obtain the Chinese medicine composition for the treatment of chronic pelvic inflammatory disease.
During medication, oral, three times on the one, every day potion, ten doses is a course for the treatment of, totally three courses for the treatment of.
Embodiment 6: a kind of Chinese medicine composition, the following raw material including by weight: Caulis Sargentodoxae 30 parts, Herba Taraxaci 30 parts, Herba Patriniae 30 parts, 15 parts of Radix Paeoniae Rubra of Radix Salviae Miltiorrhizae 15 parts, Rhizoma Corydalis 15 parts, Rhizoma Cyperi 15 parts, Rhizoma Sparganii 15 parts, Rhizoma Curcumae 15 parts.
Embodiment 7: a kind of Chinese medicine composition, the following raw material including by weight: Caulis Sargentodoxae 30 parts, Herba Taraxaci 30 parts, Herba Patriniae 30 parts, 12 parts of Radix Paeoniae Rubra of Radix Salviae Miltiorrhizae 15 parts, Rhizoma Corydalis 12 parts, Rhizoma Cyperi 12 parts, Rhizoma Sparganii 10 parts, Rhizoma Curcumae 10 parts.
Embodiment 8: a kind of Chinese medicine composition, the following raw material including by weight: Caulis Sargentodoxae 20 parts, Herba Taraxaci 20 parts, Herba Patriniae 20 parts, 15 parts of Radix Paeoniae Rubra of Radix Salviae Miltiorrhizae 12 parts, Rhizoma Corydalis 15 parts, Rhizoma Cyperi 15 parts, Rhizoma Sparganii 15 parts, Rhizoma Curcumae 15 parts.
Embodiment 9: a kind of Chinese medicine composition, the following raw material including by weight: Caulis Sargentodoxae 30 parts, Herba Taraxaci 30 parts, Herba Patriniae 30 parts, 15 parts of Radix Paeoniae Rubra of Radix Salviae Miltiorrhizae 15 parts, Rhizoma Corydalis 12 parts, Rhizoma Cyperi 15 parts, Rhizoma Sparganii 12 parts, Rhizoma Curcumae 12 parts.
Embodiment 10: a kind of Chinese medicine composition, the following raw material including by weight: Caulis Sargentodoxae 30 parts, Herba Taraxaci 30 parts, Herba Patriniae 30 parts, 15 parts of Radix Paeoniae Rubra of Radix Salviae Miltiorrhizae 15 parts, Rhizoma Corydalis 12 parts, Rhizoma Cyperi 12 parts, Rhizoma Sparganii 15 parts, Rhizoma Curcumae 15 parts.
Time prepared by above-mentioned Chinese medicine composition, weighing all of raw medicinal material by proportioning, then adding water decocts, cross leaching filtering residue and add water further decoction, filter, merge twice filtrate, dense decoct the 1/4-1/3 to filtrate volume, the Chinese medicine composition of chronic pelvic inflammatory disease must be treated.
During medication, retain medication by coloclysis, every day potion, medicine temperature 37～40 DEG C.Patient empties defecation before coloclysis, takes left lateral position (buttocks is slightly padded), coats paraffin oil with disposable anal canal, anal canal is slowly inserted 15～20cm, is slowly injected into medicinal liquid, extracts anal canal, patient left lateral position 30min, and make medicinal liquid retain more than 2h in enteric cavity.Ten doses is a course for the treatment of, totally three courses for the treatment of.
The diagnosis of chronic pelvic inflammatory disease
We are with reference to domestic literature at present: chronic pelvic inflammatory disease often fails thoroughly to treat for acute pelvic inflammatory disease, or patient's body constitution is poor, caused by course of disease delay, but also can without acute pelvic inflammatory disease medical history.The state of an illness is more obstinate, when Abwehrkraft des Koepers is poor, can have acute attack.
Pelvic inflammatory disease clinic syndrome: syndrome of accumulated dampness-heat
Diagnostic criteria: have acute pelvic inflammatory disease history and symptom, a sign person, diagnosis is many without difficulty, but should get rid of: 1. age < 18 years old or > 50 years old, gestation or women breast-feeding their children；2. the disease such as pelvic congestion or broad ligament angular vein varicose；3. the disease such as chronic appendicitis, pelvic tuberculosis, tumor of pelvic cavity, endometriosis；4. serious disease and the mental disease persons such as cardiovascular, Liver and kidney and hemopoietic system it are associated with；5. to this medicine allergy or not by regulation medication, it is impossible to judge that curative effect or data are not congruent and affect the treatment or safety judgement；6. undergoing chronic pelvic inflammation but be not damp-heat accumulation pattern of syndrome after diagnosing.
Treatment standard:
Recovery from illness: clinical symptom disappearance, uterus adnexa is without tenderness, and pelvic lump disappears, and ultrasound diagnosis uterus, adnexa are without exception.
Effective: cardinal symptom and sign are clearly better, and ultrasound diagnosis is without exception.
Effective: cardinal symptom is improved with sign, and ultrasound diagnosis enclosed mass is obviously reduced.
Invalid: symptom, sign are without significant change, and ultrasound diagnosis enclosed mass is still obvious.
In order to verify the curative effect of external medicine composition of the present invention better, by following clinical observation material, the Chinese medicine composition provided by the invention beneficial effect to chronic pelvic inflammatory disease is described.
Applicant place hospital admits to hospital patient 60 example in March, 2011～2015 year treatment in June group department of obstetrics and gynecology, 21～78 years old age, average (32.7 ± 11.8) year；The course of disease 6 months～12 years, average 22 months.Matched group outpatient service and inpatient 60 example, 21～49 years old age, average (32.8 ± 12) year；The course of disease 6 months～10 years, average 20 months.And two groups of cases are screened, the standard of eliminating is: 1. age < 18 years old or > 50 years old, gestation or women breast-feeding their children；2. the disease such as pelvic congestion or broad ligament angular vein varicose；3. the disease such as chronic appendicitis, pelvic tuberculosis, tumor of pelvic cavity, endometriosis；4. serious disease and the mental disease persons such as cardiovascular, Liver and kidney and hemopoietic system it are associated with；5. to this medicine allergy or not by regulation medication, it is impossible to judge that curative effect or data are not congruent and affect the treatment or safety judgement；6. undergoing chronic pelvic inflammation but be not damp-heat accumulation pattern of syndrome after diagnosing.
Treatment group adopts extract oral and herbal enema to retain and treats.
Matched group patient's antiinflammatory in menstrual period 3 days, continues 3 months.Monthly clean period is after 3 days, advises Kangfu anti-inflammatory bolt after patient empties's defecation (the quasi-font size of traditional Chinese medicines: Yichun company limited of Z23022143 sunflower Pharmaceutical group, every weight 2.8g) rectally, fill in anus about 5cm, every day 1-2 time, 1 tablet/time, it within 9 days, it is 1 course for the treatment of, totally 3 courses for the treatment of.
Adopt Chinese medicine composition provided by the invention to carry out treatment and carry out function score contrast with matched group, and carry out statistical analysis, specific as follows:
1. treatment group, 2 groups of patient's length of stay statistics of matched group, treatment group is the shortest 7 days, the longest 14 days, average time in hospital 9 days；Matched group is the shortest 10 days, the longest 14 days, average time in hospital 12 days.
2.1 liang group 1 course for the treatment of after comparitive study,
After two groups 1 course for the treatment of, comparitive study is specifically shown in table 1, and unit is example (%), and treatment group is evident as excellent (P < 0.05).
Table 1
2.2 liang group 2 courses for the treatment of after comparitive study
After two groups 2 courses for the treatment of, comparitive study is specifically shown in table 2, and unit is example (%), and treatment group is evident as excellent (P < 0.05).
Table 2
2.3 liang of group Clinical symptom and sign improvement are compared
Two groups of Clinical symptom and sign improvement are compared in Table 3, and unit is example (%), compares before and after two groups of lower abdominal paines, lumbosacral aching pain, profuse leukorrhea, abdominal pain during menstruation symptom treatments.Difference all statistically significant (P < 0.01)；Comparing between two groups after treatment, except profuse leukorrhea, pelvic cavity tenderness two, all the other differences are also statistically significant (P < 0.01).Treatment group is substantially better than matched group.
Table 3
Conclusion: adopt extract oral and or enema treatment undergoing chronic pelvic inflammation, its hospital stays substantially shortens, and therapeutic effect is better than treatment of control group, and its late result is better.Final statistics cure rate 55%, effective percentage 90%.
Case 1: Cao passes 43 years old hypogastric region falling inflation of Herba Marsileae Quadrifoliae, lumbosacral aching pain, and companion leucorrhea is many, yellow skin, abnormal flavour weight.Hypomenorrhea color is dark, presss from both sides clot, dripping unclean.Color ultrasound is shown: Tao Shi chamber hydrops cervix uteri nano-capsule.Once antibiotic therapy, less effective.Usually suffering from gastropathy, come institute and give simple herbal drug enema in treatment three course for the treatment of, menstruation showed increased, totally thoroughly, leucorrhea is normal, and effect is obvious.
41 years old hypogastric region falling inflation of case 2: Zhang Zhongjing, lumbosacral aching pain, companion leucorrhea is many, yellow time white during color, abnormal flavour.Menstruation is dark, presss from both sides clot, dripping unclean.Color ultrasound is shown: Tao Shi chamber hydrops.Long-term local antibiotic therapy, less effective.Come institute give Chinese medicine composition carry out being administered orally, coloclysis coordinate micro-wave therapeutic, effect is notable.
The fragrant 42 years old hypogastric region falling inflation of case 3: Dong Zhen, lumbosacral aching pain, companion leucorrhea is many, yellow time white during color, free from extraneous odour.Menstruation is dark, presss from both sides clot, dripping unclean.Color ultrasound is shown: Tao Shi chamber hydrops.Long-term local antibiotic therapy, less effective.Coming institute and give herbal enema and extract oral treatment, effect is notable.
Case 4: 38 years old hypogastric region dull pain of yellow celebrating China, lumbosacral aching pain, companion leucorrhea is many, yellow skin, abnormal flavour.Menstruation is dark, presss from both sides clot, dripping unclean.Once suffering from ectopic pregnancy before 2 years, color ultrasound is shown: Tao Shi chamber hydrops, left fallopian tube hydrops.Long-term local antibiotic therapy, less effective.Come institute give Chinese medicine composition carry out being administered orally, coloclysis coordinate micro-wave therapeutic, pelvic lump disappears, and hydrops reduces, and stomachache is alleviated, the notable case of effect.
41 years old hypogastric region dull pain of case 5: Liu Guizhi, lumbosacral aching pain, companion leucorrhea is many, yellow time white during color, abnormal flavour.Menstruation is dark, presss from both sides clot, and dripping unclean, abdominal pain in menstruation is obvious.Color ultrasound is shown: Tao Shi chamber hydrops.Long-term local antibiotic therapy, less effective.Come institute give Chinese medicine composition carry out being administered orally, coloclysis coordinate micro-wave therapeutic, effect is notable.
35 years old lower abdomen dull pain of case 6: Wu Zhi prunus mume (sieb.) sieb.et zucc., lumbosacral aching pain, companion leucorrhea is many, yellow time white during color, abnormal flavour.Menstruation is dark, presss from both sides clot, and dripping unclean, abdominal pain in menstruation is obvious.Companion's anorexia, easily tired, sleep poor, work can not be engaged in for many years.Color ultrasound is shown: Tao Shi chamber hydrops.Long-term local antibiotic therapy, less effective.Come institute give Chinese medicine composition carry out being administered orally, coloclysis coordinate micro-wave therapeutic, effect is notable.
Case 7: fresh blue 34 years old lower abdomen dull pain of phoenix, lumbosacral aching pain, companion leucorrhea is many, yellow skin, abnormal flavour.Menstruation is dark, presss from both sides clot, dripping unclean, abdominal pain in menstruation.Color ultrasound is shown: Tao Shi chamber hydrops bilateral ovaries cyst.Come institute give Chinese medicine composition carry out being administered orally, coloclysis coordinate micro-wave therapeutic, stomachache is alleviated, and cyst disappears, and effect is notable.
42 years old hidden falling inflation of lower abdomen of case 8: Zhu Xiaohong, lumbosacral aching pain, companion leucorrhea is many, yellow time white during color, abnormal flavour.Menstruation is dark, presss from both sides clot, and dripping unclean, abdominal pain in menstruation is obvious.Work can not be engaged in for many years.Color ultrasound is shown: Tao Shi chamber hydrops hysteromyoma.Long-term local antibiotic therapy, less effective.Come institute give Chinese medicine composition carry out being administered orally, coloclysis coordinate micro-wave therapeutic, remission, muscular tumor diminishes, and effect is obvious.
Case 9: to sea 43 years old hypogastric region falling inflation of English, lumbosacral aching pain, companion leucorrhea is many, yellow time white during color, abnormal flavour.Menstruation is dark, presss from both sides clot, dripping unclean, rectal tenesmus.Gynaecological examination rectum reproduction is every laying one's hand on and enclosed mass.Color ultrasound is shown: Tao Shi chamber hydrops.Long-term local antibiotic therapy, less effective.Come institute give Chinese medicine composition carry out being administered orally, coloclysis coordinate micro-wave therapeutic, effect is notable.
42 years old lower abdominal pain of case 10: Mao Aiping, lumbosacral aching pain, companion leucorrhea is many, yellow skin, abnormal flavour.Menstruation is dark, presss from both sides clot, dripping unclean.Companion's anorexia, easily tired.Color ultrasound is shown: Tao Shi chamber hydrops.Long-term local antibiotic therapy, less effective.Also once extract oral March, less effective.Come institute give Chinese medicine composition carry out being administered orally, coloclysis coordinate micro-wave therapeutic, effect is notable.
When adopting Chinese medicine composition provided by the invention to treat, it is desirable to distinguish chronic pelvic inflammatory disease symptom or based on acute pelvic inflammatory disease symptom.Chronic pelvic inflammatory disease main manifestations is that hypogastric region falling inflation, pain and lumbosacral region are ached, and accompanies low grade fever, easy tired sense.Generally use antibiotic therapy less effective merely；Distinguish whether chronic pelvic inflammatory disease forms enclosed mass, enclosed mass > 5cm, it may be considered that operative treatment.If < 5cm, all it is contemplated that adopt Chinese medicine composition provided by the invention to carry out this treatment for enclosed mass.
Additionally therapy of combining Chinese and Western medicine is now commonly used method, namely adopts extract oral, coloclysis and microwave treatment more notable.Therefore, it is possible to adopt Chinese medicine composition provided by the invention to carry out being administered orally, coloclysis coordinate micro-wave therapeutic, patients symptomatic can be made to eliminate gradually or alleviate, be a kind of determined curative effect, the non-invasive treatment methods that safe, simple to operate, expense is relatively low, be suitable for popularization and application.
It should be noted that Chinese medicine composition provided by the invention is existing is suitable for oral Chinese medicine, also there is the Chinese medicine of applicable coloclysis, if two kinds are used alone, all can effectively treat chronic pelvic inflammatory disease.If but combine and use, effect more preferably, as optimal technical scheme, and can be not construed as the restriction for the present invention.
The technical scheme that protection scope of the present invention should be recorded with claim, is protection domain including the equivalents of technical characteristic in the technical scheme that claim is recorded.Namely equivalent replacement the within the scope of this is improved, also within protection scope of the present invention.
Claims (10)
1. the Chinese medicine composition treating chronic pelvic inflammatory disease, it is characterised in that it includes following raw material by weight: Radix Salviae Miltiorrhizae 15-30 part, Radix Paeoniae Rubra 10-15 part, breast processed does not have 10-12 part, Cortex Lycii 8-10 part, Fructus Forsythiae 12-15 part, Herba Patriniae 15-20 part, Fructus Toosendan 9-12 part, Rhizoma Corydalis 10-15 part, Semen Coicis 20-30 part, Rhizoma Dioscoreae 12-15 part, Radix Rehmanniae 10-15 part, Cortex Moutan 9-12 part, Radix Notoginseng 9-15 part, Herba Hedyotidis Diffusae 20-30 part.
2. Chinese medicine composition according to claim 1, it is characterised in that: Radix Salviae Miltiorrhizae 30 parts, Radix Paeoniae Rubra 15 parts, breast processed does not have 12 parts, Cortex Lycii 10 parts, Fructus Forsythiae 15 parts, Herba Patriniae 20 parts, Fructus Toosendan 12 parts, Rhizoma Corydalis 10 parts, Semen Coicis 30 parts, Rhizoma Dioscoreae 15 parts, 15 parts of the Radix Rehmanniae, Cortex Moutan 10 parts, Radix Notoginseng 15 parts, Herba Hedyotidis Diffusae 30 parts.
3. the method for Chinese medicine composition described in preparation claim 1 or 2, it is characterised in that concretely comprising the following steps: weigh all of raw medicinal material by proportioning, then adding water decocts, and filters and obtain the Chinese medicine composition for the treatment of chronic pelvic inflammatory disease.
4. the application in the medicine of preparation treatment chronic pelvic inflammatory disease of the Chinese medicine composition described in claim 1 or 2.
5. the application in the oral drugs of preparation treatment chronic pelvic inflammatory disease of the Chinese medicine composition described in claim 1 or 2.
6. the Chinese medicine composition treating chronic pelvic inflammatory disease, it is characterized in that, it includes following raw material by weight: Caulis Sargentodoxae 20-30 part, Herba Taraxaci 20-30 part, Herba Patriniae 20-30 part, Radix Salviae Miltiorrhizae 12-15 part, Radix Paeoniae Rubra 12-15 part, Rhizoma Corydalis 12-15 part, Rhizoma Cyperi 12-15 part, Rhizoma Sparganii 10-15 part, Rhizoma Curcumae 10-15 part.
7. Chinese medicine composition according to claim 6, it is characterised in that: Caulis Sargentodoxae 30 parts, Herba Taraxaci 30 parts, Herba Patriniae 30 parts, 15 parts of Radix Paeoniae Rubra of Radix Salviae Miltiorrhizae 15 parts, Rhizoma Corydalis 15 parts, Rhizoma Cyperi 15 parts, Rhizoma Sparganii 15 parts, Rhizoma Curcumae 15 parts.
8. the method for Chinese medicine composition described in preparation claim 6 or 7, it is characterized in that, concretely comprise the following steps: weigh all of raw medicinal material by proportioning, then add water and decoct, cross leaching filtering residue and add water further decoction, filter, merge twice filtrate, dense decoct the 1/4-1/3 to filtrate volume, the Chinese medicine composition of chronic pelvic inflammatory disease must be treated.
9. the application in the medicine of preparation treatment chronic pelvic inflammatory disease of the Chinese medicine composition described in claim 6 or 7.
10. the application in the enema medicament of preparation treatment chronic pelvic inflammatory disease of the Chinese medicine composition described in claim 6 or 7.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610192449.1A CN105749037A (en) | 2016-03-30 | 2016-03-30 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610192449.1A CN105749037A (en) | 2016-03-30 | 2016-03-30 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105749037A true CN105749037A (en) | 2016-07-13 |
Family
ID=56345898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610192449.1A Pending CN105749037A (en) | 2016-03-30 | 2016-03-30 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105749037A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106310022A (en) * | 2016-11-07 | 2017-01-11 | 陈红侠 | Pelvic inflammatory disease diminishing preparation |
| CN108653672A (en) * | 2018-07-06 | 2018-10-16 | 涂世红 | A kind of Chinese medicinal enema and its clinical application method for treating chronic pelvic inflammatory disease |
| CN109276674A (en) * | 2017-07-19 | 2019-01-29 | 邓泽潭 | A kind of oral traditional Chinese medicine composition for treating pelvic inflammatory disease |
| CN109663011A (en) * | 2019-03-05 | 2019-04-23 | 莱芜职业技术学院 | A kind of medicine group that treating pelvic inflammatory disease is combined and preparation method |
| CN114504633A (en) * | 2022-03-31 | 2022-05-17 | 宁波市中医院 | Traditional Chinese medicine composition for treating chronic pelvic pain, using method and application thereof |
| CN117159674A (en) * | 2023-11-03 | 2023-12-05 | 云南中医药大学 | Gynecological traditional Chinese medicine composition for treating damp-heat stasis syndrome |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101966301A (en) * | 2010-07-13 | 2011-02-09 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating pelvic inflammation and preparation method thereof |
| CN103191375A (en) * | 2013-04-19 | 2013-07-10 | 张金梅 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory diseases |
| CN103908628A (en) * | 2014-03-17 | 2014-07-09 | 於永梅 | A traditional Chinese medicine enema medicament used for treating chronic pelvic inflammation and a preparing method thereof |
| CN104367953A (en) * | 2014-11-18 | 2015-02-25 | 郭秀珍 | Pharmaceutical composition for treating chronic pelvic inflammation |
| CN104815302A (en) * | 2015-04-14 | 2015-08-05 | 王燕 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease |
-
2016
- 2016-03-30 CN CN201610192449.1A patent/CN105749037A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101966301A (en) * | 2010-07-13 | 2011-02-09 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating pelvic inflammation and preparation method thereof |
| CN103191375A (en) * | 2013-04-19 | 2013-07-10 | 张金梅 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory diseases |
| CN103908628A (en) * | 2014-03-17 | 2014-07-09 | 於永梅 | A traditional Chinese medicine enema medicament used for treating chronic pelvic inflammation and a preparing method thereof |
| CN104367953A (en) * | 2014-11-18 | 2015-02-25 | 郭秀珍 | Pharmaceutical composition for treating chronic pelvic inflammation |
| CN104815302A (en) * | 2015-04-14 | 2015-08-05 | 王燕 | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease |
Non-Patent Citations (1)
| Title |
|---|
| 李文海，刘淑余: "慢性盆腔炎", 《中医临症绝招》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106310022A (en) * | 2016-11-07 | 2017-01-11 | 陈红侠 | Pelvic inflammatory disease diminishing preparation |
| CN109276674A (en) * | 2017-07-19 | 2019-01-29 | 邓泽潭 | A kind of oral traditional Chinese medicine composition for treating pelvic inflammatory disease |
| CN108653672A (en) * | 2018-07-06 | 2018-10-16 | 涂世红 | A kind of Chinese medicinal enema and its clinical application method for treating chronic pelvic inflammatory disease |
| CN109663011A (en) * | 2019-03-05 | 2019-04-23 | 莱芜职业技术学院 | A kind of medicine group that treating pelvic inflammatory disease is combined and preparation method |
| CN114504633A (en) * | 2022-03-31 | 2022-05-17 | 宁波市中医院 | Traditional Chinese medicine composition for treating chronic pelvic pain, using method and application thereof |
| CN117159674A (en) * | 2023-11-03 | 2023-12-05 | 云南中医药大学 | Gynecological traditional Chinese medicine composition for treating damp-heat stasis syndrome |
| CN117159674B (en) * | 2023-11-03 | 2024-01-09 | 云南中医药大学 | Gynecological traditional Chinese medicine composition for treating damp-heat stasis syndrome |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102370725B (en) | A kind of compound Chinese medicinal preparation treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN105749037A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease and preparation method and application thereof | |
| CN102940721B (en) | Medicine for treating chronic pelvic inflammation | |
| CN103908628B (en) | A kind of herbal enema medicament treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN102228603B (en) | Chinese medicine for treating retention of urine | |
| CN105250723A (en) | Medicine for treating diabetes | |
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN103393989B (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN102488875B (en) | Traditional Chinese medicine for treating acquired dysmenorrhea | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104258289A (en) | Traditional Chinese medicine for treating enteritis | |
| CN103550728B (en) | A kind ofly treat the Chinese medicine composition that dampness-heat in the liver and gallbladder causes hypochondriac pain | |
| CN102847074B (en) | Blood stasis removing pill for treating ankylosing spondylitis | |
| CN104173856A (en) | Traditional Chinese medicine composition for treating morbid leukorrhea | |
| CN102274445A (en) | Cassia twig common burreed rhizome tumor eliminating pills | |
| CN103386091B (en) | Rupikang traditional Chinese medicine composition and capsule preparation method | |
| CN105797046A (en) | Traditional Chinese medicine composition for uterine fibroid treatment and postoperative nursing | |
| CN105456921A (en) | External traditional Chinese medicinal composition for treating cold womb and preparation method of external traditional Chinese medicinal composition | |
| CN104887809A (en) | Medicine for treating gynecologic inflammation and preparation method thereof | |
| CN104491775A (en) | Tradtional Chinese medicament for treating post cerebral hemorrhage depressions | |
| CN103417716A (en) | Hypoglycemic Tongluo tablet for treating diabetic peripheral neuropathy | |
| CN103223046B (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
| CN104435362B (en) | A kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease | |
| CN103055072A (en) | Traditional Chinese medicine composition for treating stranguria | |
| CN106511715A (en) | Traditional Chinese medicine decoction for treating hemorrhoids, and preparation method therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160713 |